Russia first nation to finish human trials for COVID vaccine

The university was conducting trials on the vaccine candidate produced by Gamalei Institute of Epidemiology and Microbiology, Russia

As the world reels under the rising COVID-19 cases, Russia’s Sechenov University has successfully completed the world’s first clinical trials of coronavirus vaccine on humans, media reports said on Sunday.

The director of the Institute for Translational Medicine and Biotechnology Vadim Tarasov confirmed the development to media.

“Sechenov University has successfully completed tests on volunteers of the world`s first vaccine against coronavirus,” Tarasov said.

The university was conducting trials on the vaccine candidate produced by Gamalei Institute of Epidemiology and Microbiology, Russia. They began trials on 18 June.

The objective of this stage of the trials was to test the vaccine’s safety for human health, which was successfully done, said Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University.

“The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market,” Lukashev told Sputnik, sources said.

Further plans on vaccine development are being determined by the developers, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production.

“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research centre that is able to participate in the creation of such important and complex products as drugs … We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are currently underway,” Tarasov added.

With this Russia has become the first nation to complete human clinical trials of COVID-19 vaccine and the results prove the medication`s effectiveness.

However, there was no further information on when this vaccine would enter the commercial production stage.

There are at least 21 vaccines currently under key trials, according to the World Health Organisation (WHO).

As of Sunday morning, the global number of COVID-19 cases stood at 12,681,472, while the death toll climbing to 564,420, according to Johns Hopkins University in the US.

The US accounted for the world’s highest number of infections and fatalities at 3,245,158 and 134,764 while Brazil is in the second place with 1,839,850 infections and 71,469 deaths.

More than a hundred vaccines against the novel coronavirus are currently under development or trials, globally. The coronavirus has infected more than 12 million people around the world, till now.

Sirf News Network

By Sirf News Network